vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Paylocity Holding Corp (PCTY). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $387.0M, roughly 1.3× Paylocity Holding Corp). Paylocity Holding Corp runs the higher net margin — 13.0% vs 6.8%, a 6.1% gap on every dollar of revenue. On growth, Paylocity Holding Corp posted the faster year-over-year revenue change (11.3% vs -1.7%). Over the past eight quarters, Paylocity Holding Corp's revenue compounded faster (2.7% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Paylocity Holding Corporation is an American provider of cloud-based payroll, , spend management, and human capital management (HCM) software.
MD vs PCTY — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $387.0M |
| Net Profit | $33.7M | $50.2M |
| Gross Margin | — | 72.9% |
| Operating Margin | 9.9% | 18.2% |
| Net Margin | 6.8% | 13.0% |
| Revenue YoY | -1.7% | 11.3% |
| Net Profit YoY | 10.5% | 34.0% |
| EPS (diluted) | $0.40 | $0.92 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $387.0M | ||
| Q3 25 | $492.9M | $378.9M | ||
| Q2 25 | $468.8M | $369.9M | ||
| Q1 25 | $458.4M | $421.1M | ||
| Q4 24 | $502.4M | $347.7M | ||
| Q3 24 | $511.2M | $333.1M | ||
| Q2 24 | $504.3M | $324.7M | ||
| Q1 24 | $495.1M | $366.8M |
| Q4 25 | $33.7M | $50.2M | ||
| Q3 25 | $71.7M | $48.0M | ||
| Q2 25 | $39.3M | $48.6M | ||
| Q1 25 | $20.7M | $91.5M | ||
| Q4 24 | $30.5M | $37.5M | ||
| Q3 24 | $19.4M | $49.6M | ||
| Q2 24 | $-153.0M | $48.8M | ||
| Q1 24 | $4.0M | $85.3M |
| Q4 25 | — | 72.9% | ||
| Q3 25 | — | 73.9% | ||
| Q2 25 | — | 73.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 72.6% | ||
| Q3 24 | — | 74.4% | ||
| Q2 24 | — | 74.0% | ||
| Q1 24 | — | 77.8% |
| Q4 25 | 9.9% | 18.2% | ||
| Q3 25 | 13.8% | 19.6% | ||
| Q2 25 | 12.8% | 17.9% | ||
| Q1 25 | 7.0% | 30.2% | ||
| Q4 24 | 7.8% | 13.4% | ||
| Q3 24 | 6.6% | 19.3% | ||
| Q2 24 | -31.3% | 19.4% | ||
| Q1 24 | 3.2% | 29.0% |
| Q4 25 | 6.8% | 13.0% | ||
| Q3 25 | 14.5% | 12.7% | ||
| Q2 25 | 8.4% | 13.1% | ||
| Q1 25 | 4.5% | 21.7% | ||
| Q4 24 | 6.1% | 10.8% | ||
| Q3 24 | 3.8% | 14.9% | ||
| Q2 24 | -30.3% | 15.0% | ||
| Q1 24 | 0.8% | 23.3% |
| Q4 25 | $0.40 | $0.92 | ||
| Q3 25 | $0.84 | $0.86 | ||
| Q2 25 | $0.46 | $0.87 | ||
| Q1 25 | $0.24 | $1.61 | ||
| Q4 24 | $0.37 | $0.66 | ||
| Q3 24 | $0.23 | $0.88 | ||
| Q2 24 | $-1.84 | $0.85 | ||
| Q1 24 | $0.05 | $1.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $162.5M |
| Total DebtLower is stronger | $570.5M | $81.3M |
| Stockholders' EquityBook value | $865.9M | $1.1B |
| Total Assets | $2.2B | $7.0B |
| Debt / EquityLower = less leverage | 0.66× | 0.07× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $162.5M | ||
| Q3 25 | $340.1M | $165.2M | ||
| Q2 25 | $224.7M | $398.1M | ||
| Q1 25 | $99.0M | $477.8M | ||
| Q4 24 | $229.9M | $482.4M | ||
| Q3 24 | $103.8M | $778.5M | ||
| Q2 24 | $19.4M | $401.8M | ||
| Q1 24 | $8.0M | $492.7M |
| Q4 25 | $570.5M | $81.3M | ||
| Q3 25 | $577.2M | $81.3M | ||
| Q2 25 | $583.9M | $162.5M | ||
| Q1 25 | $590.5M | $243.8M | ||
| Q4 24 | $597.1M | $325.0M | ||
| Q3 24 | — | $325.0M | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $1.1B | ||
| Q3 25 | $890.7M | $1.1B | ||
| Q2 25 | $833.8M | $1.2B | ||
| Q1 25 | $789.2M | $1.2B | ||
| Q4 24 | $764.9M | $1.2B | ||
| Q3 24 | $732.5M | $1.1B | ||
| Q2 24 | $706.5M | $1.0B | ||
| Q1 24 | $856.2M | $1.1B |
| Q4 25 | $2.2B | $7.0B | ||
| Q3 25 | $2.2B | $4.2B | ||
| Q2 25 | $2.1B | $4.4B | ||
| Q1 25 | $2.0B | $5.2B | ||
| Q4 24 | $2.2B | $5.3B | ||
| Q3 24 | $2.1B | $4.0B | ||
| Q2 24 | $2.0B | $4.2B | ||
| Q1 24 | $2.2B | $5.0B |
| Q4 25 | 0.66× | 0.07× | ||
| Q3 25 | 0.65× | 0.07× | ||
| Q2 25 | 0.70× | 0.13× | ||
| Q1 25 | 0.75× | 0.20× | ||
| Q4 24 | 0.78× | 0.28× | ||
| Q3 24 | — | 0.29× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $117.0M |
| Free Cash FlowOCF − Capex | — | $113.6M |
| FCF MarginFCF / Revenue | — | 29.4% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | 3.39× | 2.33× |
| TTM Free Cash FlowTrailing 4 quarters | — | $461.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $117.0M | ||
| Q3 25 | $137.3M | $86.5M | ||
| Q2 25 | $137.2M | $86.6M | ||
| Q1 25 | $-117.5M | $186.0M | ||
| Q4 24 | $133.0M | $54.2M | ||
| Q3 24 | $91.8M | $91.5M | ||
| Q2 24 | $107.0M | $79.9M | ||
| Q1 24 | $-125.2M | $167.5M |
| Q4 25 | — | $113.6M | ||
| Q3 25 | — | $82.7M | ||
| Q2 25 | — | $81.1M | ||
| Q1 25 | — | $183.7M | ||
| Q4 24 | — | $51.2M | ||
| Q3 24 | — | $89.1M | ||
| Q2 24 | — | $73.6M | ||
| Q1 24 | — | $162.0M |
| Q4 25 | — | 29.4% | ||
| Q3 25 | — | 21.8% | ||
| Q2 25 | — | 21.9% | ||
| Q1 25 | — | 43.6% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 26.8% | ||
| Q2 24 | — | 22.7% | ||
| Q1 24 | — | 44.2% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | — | 1.5% |
| Q4 25 | 3.39× | 2.33× | ||
| Q3 25 | 1.91× | 1.80× | ||
| Q2 25 | 3.49× | 1.78× | ||
| Q1 25 | -5.66× | 2.03× | ||
| Q4 24 | 4.36× | 1.45× | ||
| Q3 24 | 4.72× | 1.84× | ||
| Q2 24 | — | 1.64× | ||
| Q1 24 | -31.03× | 1.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PCTY
| Recurring Fees | $370.1M | 96% |
| Implementation Services And Other | $16.9M | 4% |
